MedCity News May 23, 2025
In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come.
Our Season 2 – Innovations in Oncology – continues with a focus on precision medicine. I talk with CEO of Helix, James Lu, who had an interesting take on how precision medicine is evolving.
Below, you will find the video, audio and transcript:
Here is the audio-only version
Here is the transcript:
Arundhati: Welcome to the Met City Pivot Podcast. I’m your host. We are continuing with our focus on oncology this season. Precision medicine has been hailed as a key advancement in the battle against cancer, but how successful has it truly...
Today's Sponsors
Today's Sponsor